Latest Breaking News On - ஜான்சன் நுரையீரல் புற்றுநோய் முயற்சி - Page 1 : comparemela.com

Everest Medicines Appoints Jennifer Yang as Chief Scientific Officer News provided by Share this article Share this article SHANGHAI, April 14, 2021 /PRNewswire/ Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, announced today the appointment of Dr. Jennifer Yang as chief scientific officer. Dr. Yang has two decades of leadership experience in drug discovery and development at global pharmaceutical companies. We are pleased to welcome Dr. Yang to Everest s leadership team. Jennifer s deep expertise in drug discovery and translational medicine combined with her extensive experience in global development will be invaluable to the Company.  She will establish a strong discovery organization that contributes to the strategic expansion of our clinical development pipeline, said Kerry Blancha

United statesJennifer yangKerry blanchardEli lillyUniversity of utahEccles institute of human geneticsPfizer inc oncology research unitJanssen china research development centerFudan universitySouthern illinois universityJohnson lung cancer initiativeDiscovery centerGreater chinaEverest medicinesEverest medicineLung cancer initiative